CalciMedica, Inc. Earnings Per Share (Basic)
CalciMedica, Inc. (CALC) reported Earnings Per Share (Basic) of -$0.45 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- CalciMedica, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.45.
- CalciMedica, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.31.
- CalciMedica, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.68.
- CalciMedica, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.52.
- CalciMedica, Inc. earnings per share, basic for fiscal 2025 was -$1.97.
- CalciMedica, Inc. earnings per share, basic for fiscal 2024 was -$1.22.
- CalciMedica, Inc. earnings per share, basic for fiscal 2023 was -$7.66.
- CalciMedica, Inc. earnings per share, basic for fiscal 2022 was -$111.16.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.45 10-Q · filed 2026-08-11 | -$0.16 10-Q · filed 2026-08-11 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2026-03-31 | $0.31 10-Q · filed 2026-05-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.97 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$0.52 10-Q · filed 2025-11-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.28 10-Q · filed 2025-11-12 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-06-30 | -$0.40 10-Q · filed 2026-08-11 | -$0.76 10-Q · filed 2026-08-11 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.57 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-05-12 | ||||
| 2024-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.22 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | -$0.50 10-Q · filed 2025-11-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.88 10-Q · filed 2025-11-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.36 10-Q · filed 2025-08-12 | -$0.37 10-Q · filed 2025-08-12 | -$0.90 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-08-12 | ||||
| 2024-03-31 | $0.01 10-Q · filed 2025-05-14 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$2.23 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||||
| 2023-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.54 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$2.65 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$7.66 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$0.82 10-Q · filed 2024-11-13 | -$1.93 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$7.43 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | -$1.11 10-Q · filed 2024-08-12 | -$7.86 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | -$23.43 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$111.16 10-K · filed 2024-03-28 | -$1.66 10-K · filed 2023-03-09 | ||||||
| 2022-09-30 | -$31.04 10-Q · filed 2023-11-09 | -$0.46 10-Q · filed 2022-11-10 | -$113.24 10-Q · filed 2023-11-09 | -$1.32 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | -$36.55 10-Q · filed 2023-08-11 | -$0.38 10-Q · filed 2022-08-12 | -$82.42 10-Q · filed 2023-08-11 | -$0.86 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | -$46.13 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.15 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.69 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$0.38 10-Q · filed 2022-11-10 | -$0.74 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.28 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.36 10-Q · filed 2022-08-12 | -$0.91 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |